Exploratory evaluation of bezlotoxumab on outcomes associated with clostridioides difficile infection in MODIFY I/II Participants with Cancer

  1. Cornely, O.A.
  2. Mullane, K.M.
  3. Birch, T.
  4. Hazan-Steinberg, S.
  5. Nathan, R.
  6. Bouza, E.
  7. Calfee, D.P.
  8. Ellison, M.C.
  9. Wong, M.T.
  10. Dorr, M.B.
Aldizkaria:
Open Forum Infectious Diseases

ISSN: 2328-8957

Argitalpen urtea: 2020

Alea: 7

Zenbakia: 2

Mota: Artikulua

DOI: 10.1093/OFID/OFAA038 GOOGLE SCHOLAR lock_openSarbide irekia editor